Alkermes' $194M payment from Janssen gets approval from court
A New York court has approved Johnson & Johnson’s Janssen paying Alkermes $194 million in its arbitration case.
The case comes from two license agreements …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
